The role of myeloid colony-stimulating factors in the treatment of acute lymphoblastic leukemia more questions than answers?

Leukemia and Lymphoma

Volumn 50, Issue 11, 2009, Pages 1737-1739

  Ram, Ron ^a,b   Raanani, Pia ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; MYELOID COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER CHEMOTHERAPY; LEUKOCYTE COUNT; NEUTROPENIA; NOTE; PRIORITY JOURNAL;

GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; KAPLAN-MEIERS ESTIMATE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 71049190450     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428190903234013     Document Type: Note

References (19)

1. Ohsaka A, Kitagawa S, Sakamoto S, et al. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma. Blood 1989;74:2743-2748. (Pubitemid 20007801)
2. Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood 1991;78:2791-2808.
3. Hallböök H, Björkholm M, Hägglund H, et al. Does granulocyte colony-stimulating factor improve long-term outcome in adult acute lymphoblastic leukemia? Leuk Lymphoma 2009;50:1872-1874.
4. Geissler K, Koller E, Hubmann E, et al. Granulocyte colonystimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia - a randomized phase-III study. Blood 1997;90:590-596.
5. Ottmann OG, Hoelzer D, Gracien E, et al. Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial. Blood 1995;86:444-450.
6. Thomas X, Boiron JM, Huguet F, et al. Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study. Hematol J 2004;5:384-394.
7. Larson RA, Dodge RK, Linker CA, et al. A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood 1998;92:1556-1564.
8. Holowiecki J, Giebel S, Krzemien S, et al. G-CSF administered in time-sequenced setting during remission induction and consolidation therapy of adult acute lymphoblastic leukemia has beneficial influence on early recovery and possibly improves long-term outcome: a randomized multicenter study. Leuk Lymphoma 2002;43:315-325.
9. Sasse EC, Sasse AD, Brandalise S, et al. Colony-stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia. Cochrane Database Syst Rev 2005;3:CD004139.
10. Sung L, Alibhai SM, Beyene J, et al. Hematopoietic colonystimulating factor priming does not influence survival in acute myeloid leukemia: a meta-analysis of randomized trials. Leukemia 2009;23:811-813.
11. Becker PS. Growth factor priming in therapy of acute myelogenous leukemia. Curr Hematol Rep 2004;3:413-418.
12. Inatomi Y, Toyama K, Clark SC, et al. Combinations of stem cell factor with other hematopoietic growth factors enhance growth and sensitivity to cytosine arabinoside of blast progenitors in acute myelogenous leukemia. Cancer Res 1994;54:455-462.
13. Lowenberg B, van Putten W, Theobald M, et al. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. N Engl J Med 2003;349:743-752.
14. Wheatley K, Goldstone AH, Littlewood T, et al. Randomized placebo-controlled trial of granulocyte colony-stimulating factor (G-CSF) as supportive care after induction chemotherapy in adult patients with acute myeloid leukaemia: a study of the United Kingdom Medical Research Council Adult Leukaemia Working Party. Br J Haematol 2009;146:54-63.
15. Matsushita K, Arima N, Ohtsubo H, et al. Granulocytecolony- stimulating factor-induced proliferation of primary adult T-cell leukaemia cells. Br J Haematol 1997;96:715-723.
16. Shinjo K, Takeshita A, Ohnishi K, et al. Granulocyte colonystimulating factor receptor at various differentiation stages of normal and leukemic hematopoietic cells. Leuk Lymphoma 1997;25:37-46.
17. Mielcarek M, Martin PJ, Torok-Storb B. Suppression of alloantigen-induced T-cell proliferation byCD14tcells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 1997;89:1629-1634.
18. Rutella S, Zavala F, Danese S, et al. Granulocyte colonystimulating factor: a novel mediator of T cell tolerance. J Immunol 2005;175:7085-7091.
19. Tanaka J, Mielcarek M, Torok-Storb B. Impaired induction of the CD28-responsive complex in granulocyte colony-stimulating factor mobilized CD4 T cells. Blood 1998;91: 347-352.